NCT04801693View on ClinicalTrials.gov

A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated and Taken up by the Body With or Without Food

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

April 25, 2022

Study Completion Date

April 25, 2022

Conditions
Healthy
Interventions
DRUG

BI 1819479

BI 1819479

DRUG

Placebo

Placebo

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04801693 - A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated and Taken up by the Body With or Without Food | Biotech Hunter | Biotech Hunter